SCHEDULE: Intracoastal Capital Discloses 9.99% Stake in GRI Bio

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 9.99% beneficial ownership stake in GRI Bio, Inc. common stock.

Summary

• Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (the "Reporting Persons") collectively beneficially own 1,097,858 shares of GRI Bio, Inc. common stock.
• This ownership represents approximately 9.99% of GRI Bio, Inc.'s common stock.
• The beneficially owned shares consist of 229,347 shares directly held by Intracoastal Capital LLC and 868,511 shares issuable upon the exercise of Intracoastal Warrant 1.
• The percentage of class is calculated based on 10,121,060 shares of Common Stock outstanding as of December 19, 2025, as reported by the Issuer, plus the 868,511 shares from Intracoastal Warrant 1.
• Intracoastal Warrants 1, 2, 3, and 4 contain blocker provisions that prevent the holder from exercising them to the extent that such exercise would result in beneficial ownership exceeding 9.99% (for Warrant 1) or 4.99% (for Warrants 2, 3, and 4).
• Without these blocker provisions, the Reporting Persons would have been deemed to beneficially own 3,054,350 shares of Common Stock.
• The Reporting Persons certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as moderately positive, as a significant stake by an institutional investor often implies a belief in the company's value, even if the blocker provisions suggest a cautious approach to control.

Positives

• A significant institutional investor, Intracoastal Capital LLC, holds a substantial stake, which can signal confidence in GRI Bio, Inc.'s prospects.
• The ownership position, just below the 10% threshold, suggests a strategic investment without immediately triggering more extensive regulatory reporting requirements.

Negatives

• The presence of blocker provisions in the warrants limits the immediate exercisability of a larger potential stake, which could be viewed as a cautious approach rather than full commitment to increasing ownership beyond the current reported percentage.

Risks

• The blocker provisions in the warrants mean that the full potential ownership of 3,054,350 shares is not currently realized, which could limit the reporting persons' influence or upside if they choose not to exceed the thresholds.
• The filing itself does not detail company-specific operational or financial risks, focusing solely on beneficial ownership disclosure.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that a significant stake by an investment firm like Intracoastal Capital LLC in a biotechnology company such as GRI Bio, Inc. can signal a vote of confidence in the company's long-term prospects or its underlying assets. Such disclosures are common for active investors seeking to establish a position without immediately triggering more stringent reporting requirements associated with larger, more activist stakes.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake could be viewed positively, potentially increasing investor confidence and liquidity.
• Company Management: Awareness of a large shareholder may influence strategic decisions, though the reporting persons state they are not seeking to influence control.

Key Dates

Recommendation

The disclosure of a significant 9.99% beneficial ownership by Intracoastal Capital LLC, a sophisticated investor, suggests a positive long-term view on GRI Bio, Inc. However, without additional operational or financial details from the company, a 'hold' recommendation is prudent. Investors should monitor future filings and company performance to assess the full implications of this substantial stake.

Keywords

GRI Bio Inc., Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Schedule 13G, beneficial ownership, common stock, warrants, institutional investment, equity stake, SEC filing